Lipid-polymer nanocarrier platform enables X-ray induced photodynamic therapy against human colorectal cancer cells - 18/10/22

Abstract |
In this study, we brought together X-ray induced photodynamic therapy (X-PDT) and chemo-drug (5-FU) for the treatment on colorectal cancer cells. This was achieved by developing a lipid-polymer hybrid nanoparticle delivery system (FA-LPNPs-VP-5-FU). It was prepared by incorporating a photosensitizer (verteporfin), chemotherapy drug (5-FU) and a targeting moiety (folic acid) into one platform. The average size of these nanoparticles was around 100 nm with low polydispersity. When exposed to clinical doses of 4 Gy X-ray radiation, FA-LPNPs-VP-5-FU generated sufficient amounts of reactive oxygen species, triggering the apoptosis and necrosis pathway of cancer cells. Our combined X-PDT and chemo-drug strategy was effective in inhibiting cancer cells’ growth and proliferation. Cell cycle analyses revealed that our treatment induced G2/M and S phase arrest in HCT116 cells. Our results indicate that this combined treatment provides better antitumour effect in colorectal cancer cells than each of these modalities alone. This may offer a novel approach for effective colorectal cancer treatment with reduced off-target effect and drug toxicity.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | The lipid-polymer nanocarrier platform is exclusively made from FDA approved components. |
• | X-PDT combined with chemo-drug in this platform effectively inhibited colorectal cancer cells’ growth and proliferation. |
• | This combined treatment induced G2/M and S phase arrest in HCT116 cells. |
Key words : X-PDT, Targeted lipid-polymer nanoparticles, Verteporfin, 5-FU, Colorectal cancer
Plan
Vol 155
Article 113837- novembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
